Novadaq Technologies (NASDAQ:NVDQ; TSX:NDQ) said Karen Licitra will be joining the company’s board of directors.
Ms. Licitra has a track record of accomplishments in sales, marketing, commercial and general management in the global healthcare industry. In her 30-plus-year career with Johnson & Johnson (NYSE:JNJ), she most recently served as corporate VP worldwide government affairs and policy, before retiring in August 2015.
Prior to her role in governmental affairs, Ms. Licitra was worldwide chairman, Global Medical Solutions Group within J&J’s medical device and diagnostics segment. She was named to Fortune’s 50 Most Powerful Women in Business list in 2012.
“Karen is a seasoned leader who brings an impressive wealth of healthcare knowledge and executive management expertise to Novadaq,” Bill MacKinnon, chairman, said in a statement.
In conjunction with Ms. Licitra’s appointment, Harold Koch will be resigning from the Novadaq board and chairman of the governance committee.
